Four cyclotetrapeptides containing one (1, 2) or two (3, 4) chiral amino acids have been C-alkylated or C-hydroxyalkylated through Li' or phosphazenium (P4.H') enolates. The reactions are completely diastereoselective (by NMR or HPLC analysis) with respect to the newly formed backbone stereogenic centres (Tables 2 and 3 ) . The reactivity of the polylithiated species responsible for these alkylations is such that only highly reactive electrophiles (MeI, BnBr, primary allylic halides, aldehydes, CO, ) can be employed. It is shown that the position, and thus the chirality sense, of the newly formed stereogenic centre in a given cyclotetrapeptide backbone is controlled by the positioning of N-methyl groups in the starting material (cf. cycio(-MeLeu-Gly-D-Ala-Sar-) (3) and cyclo(-Leu-Sar-MeuAla-Gly-) (4) in Scheme I). With Schwesinger's phosphazene P4-base, all NH groups are first benzylated and C-benzylation then takes place at a sarcosine, rather than an N-benzylglycine residue (Table 3 ) . In contrast to open-chain N-benzyl peptides, the N-benzylated cyclotetrapeptides could not be debenzylated under dissolving-metal conditions (Na/NH,). Conformational analysis (NMR spectroscopy and X-ray diffraction)shows that the prevailing species have cisltranslcisltrans (ctct) peptide bonds (zigzag conformation of Ci backbone symmetry, Figs. 2 4 ) . However, a hitherto unknown conformation of cyclotetrapeptides has been found in CDC1, solutions of the hydroxyalkylated products 18-21 (obtained with EtCHO and PhCHO as electrophiles; Fig. 4 ) . The new conformation has four trans peptide bonds and is believed to result mainly from intramolecular H-bond formation, involving the newly generated alkyl-or arylserine residue. This assumption has also been supported by modelling (TRIPOS force field, SYBYL, see Fig.5 and Table 6 ) . The structure may be considered as ab-turn mimic.